Hypothermic and antipyretic effects of 3-methyl- and 3-phenyl-5-hydroxy-5-trichloromethyl-4,5-dihydro-1H-pyrazole-1-carboxyamides in mice

European Journal of Pharmacology

Volumn 451, Issue 2, 2002, Pages 141-147

  Souza, Fabiane R ^a   Souza, Vanessa T ^a   Ratzlaff, Viviane ^a   Borges, Lysandro P ^a   Oliveira, Marlí R ^a   Bonacorso, Helio G ^a   Zanatta, Nilo ^a   Martins, Marcos A P ^a   Mello, Carlos F ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Antipyresis; Fever; Hypothermia; Lipopolysaccharide; Mouse; Pyrazole

Indexed keywords

3 METHYL 5 HYDROXY 5 TRICHLOROMETHYL 4,5 DIHYDRO 1H PYRAZOLE 1 CARBOXAMIDE; 3 PHENYL 5 HYDROXY 5 TRICHLOROMETHYL 4,5 DIHYDRO 1H PYRAZOLE 1 CARBOXAMIDE; ANTIPYRETIC AGENT; BACTERIUM LIPOPOLYSACCHARIDE; DIPYRONE; PYRAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPYRETIC ACTIVITY; ARTICLE; BASAL BODY TEMPERATURE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; FEVER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECTUM TEMPERATURE; TEMPERATURE MEASUREMENT;

ANALGESICS, NON-NARCOTIC; ANIMALS; BODY TEMPERATURE; DIPYRONE; FEVER; HYPOTHERMIA; LIPOPOLYSACCHARIDES; MALE; MICE; PYRAZOLES; PYRAZOLONES;

EID: 0037072524     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)02225-2     Document Type: Article

References (38)

1. Adam D., Stankov G. Treatment of fever in childhood. Eur. J. Pediatr. 153:1994;394-402.
2. Aguirre-Banuelos P., Granados-Soto V. Evidence for a peripheral mechanism of action for the potentiation of the antinociceptive effect of morphine by dipyrone. J. Pharmacol. Toxicol. 42:1999;79-85.
3. Arellano F., Sacristan S.A. Metamizole: reassessment of its therapeutic role. Eur. J. Clin. Pharmacol. 38:1990;617-619.
4. Bansinath M., Bose A.C., Hema S., Guruswami M.M. Interaction of metamizol with some hypnotics in rats. Arch. Int. Pharmacodyn. Ther. 260:1982;14-27.
5. Beirith A., Santos A.R., Rodrigues A.L., Creczynski-Pasa T.B., Calixto J.B. Spinal and supraspinal antinociceptive action of dipyrone in formalin, capsaicin and glutamate tests. Study of the mechanism of action. Eur. J. Pharmacol. 345:1998;233-245.
6. Benamar K., Xin L., Geller E.B., Adler M.W. Blockade of lipopolysaccharide-induced fever by a μ-opioid receptor-selective antagonist in rats. Eur. J. Pharmacol. 401:2000;161-165.
7. Beutler B., Beutler S.M. The pathogenesis of fever. Bennett C., Plum F. Cecil Textbook of Medicine. 1992;1533-1535 Saunders, Philadelphia.
8. Blanqué R., Meakin C., Millet S., Gardner C.R. Dual mechanisms of action of interferon-γ in potentiating responses to LPS in mice IL1, TNFα and IL6 production in serum and hypothermia. Gen. Pharmacol. 32:1999;453-461.
9. Bonacorso H.G., Oliveira M.R., Wentz A.P., Wastowski A.D., Oliveira A.B., Höerner M., Zanatta N., Martins M.A.P. Haloacetylated enol ethers: 12[18]. Regiospecific synthesis and structural determination of stable 5-hydroxy-1H-pyrazolines. Tetrahedron. 55:1999;345-352.
10. Borne R.F. Nonsteroidal anti-inflammatory drugs. Foye W.O., Lemke T.L., Williams D.A. Medicinal Chemistry. 1995;535-580 Williams and Wilkins, Baltimore.
11. Briese E., Cabanac M. Stress hyperthermia: physiological arguments that it is a fever. Physiol. Behav. 49:1990;1153-1157.
12. Campos C., Gregorio R., García-Nieto R., Gago F., Ortiz P., Alemany S. Regulation of cyclooxygenase activity by metamizol. Eur. J. Pharmacol. 378:1999;339-347.
13. Cao C., Matsumura K., Yamagata K., Watanabe Y. Involvement of cyclooxygenase-2 in LPS-induced fever and regulation of its mRNA by LPS in the rat brain. Am. J. Physiol. 272:1997;1712-1725.
14. Dogan M.D., Ataoglu H., Akarsu E.S. Effects of different serotypes of Escherichia coli lipopolysaccharides on body temperature in rats. Life Sci. 67:2000;2319-2329.
15. Elmquist J.K., Scammell T.E., Saper C.B. Mechanisms of CNS response to a systemic immune challenge: the febrile response. Trends Neurosci. 20:1997;565-570.
16. Elsbach P. Mechanism of disposal of bacterial lipopolysaccharides by animal host. Microbes Infect. 2:2000;1171-1180.
17. Feldberg W., Saxena P.N. Prostaglandins, endotoxin and lipid A on body temperature in rats. J. Physiol. 249:1975;601-615.
18. Insel P.A. Analgesic-antipyretic and antiinflammatory agents and drugs employed in the treatment of gout. Hardman J.G., Limbird L.E., Molinoff P.B., Ruddon R.W., Gilman A.G. The Pharmacological Basis of Therapeutics. 1996;617-657 McGraw-Hill, New York.
19. Josa M., Urizar J.P., Rapado J., Dios-Viéitez C., Castañeda-Hernández G., Flores-Murrieta F., Renedo M.J., Troconiz I.F. Pharmacokinetic/pharmacodynamic modeling of antipyretic and anti-inflammatory effects of naproxen in the rat. J. Pharmacol. Exp. Ther. 297:2001;198-205.
20. Kluger M.J. Fever: role of pyrogens and cryogens. Physiol. Rev. 71:1991;93-127.
21. Laporte J.R., Carné X. Blood dyscrasias and the relative safety of non-narcotic analgesics. Lancet. 4:1987;809.
22. Lecannelier S. Antiinflamatorios no esteroideos. Marcondes J. Farmacología. 1976;503-515 Intermédica, Buenos Aires.
23. - mice. Brain Res. 825:1999;86-94.
24. Long N.C., Morimoto A., Nakamori T., Muraki N. The effect of physical restraint on IL-1β and LPS-induced fever. Physiol. Behav. 50:1991;625-628.
25. Lorenzetti B.B., Ferreira S.H. Activation of the arginine-nitric oxide pathway in primary sensory neurons contributes to dipyrone-induced spinal and peripheral analgesia. Inflamm. Res. 45:1996;308-311.
26. Rowsey P.J., Gordon C.J. A peripheral mechanism of fever: differential sensitivity to the antipyretic action of methyscopolamine. Auton. Neurosci. 85:2000;148-155.
27. Schwartz J.I., Chan C.C., Mukhopadhyay S., Mcbride K.J., Jones T.M., Adcock S., Moritz C., Hedges J., Grasing K., Dobratz D., Cohen R.A., Davidson M.H., Bachmann K.A., Gertz B.J. Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humans. Clin. Pharmacol. Ther. 65:1999;653-660.
28. 2 production in aged male rats. Mech. Ageing Dev. 85:1995;65-72.
29. Shimada S.G., Otterness I.G., Stitt J.T. A study of the mechanism of action of the mild analgesic dipyrone. Agents Actions. 41:1994;188-192.
30. Soszynski D. The inhibition of nitric oxide synthase suppresses LPS- and psychological-stress-induced fever in rats. Physiol. Behav. 72:2001;65-72.
31. Souza F.R., Fighera M.R., Lima T.T.F., Bastiani J., Barcellos I.B., Almeida C.E., Oliveira M.R., Bonacorso H.G., Flores A.E., Mello C.F. 3-Methyl-5-hydroxy-5-trichloromethyl-1H-1-pyrazolcarboxyamide (MPCA) induces antinociception. Pharmacol. Biochem. Behav. 68:2001;525-530.
32. Taniguchi Y., Yokoyama K., Inui K., Deguchi Y., Furukawa K., Noda K. Inhibition of brain cyclooxygenase-2 activity and the antipyretic action of nimesulid. Eur. J. Pharmacol. 330:1997;221-229.
33. The International Agranulocytosis and Aplastic Anemia Study Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. JAMA. 256:1986;1749-1757.
34. Tolchard S., Hare A.S., Nutt D.J., Clarke G. TNF alpha mimics the endocrine but not thermoregulatory responses of bacterial lipopolysaccharide (LPS): correlation with FOS-expression in the brain. Neuropharmacology. 35:1996;243-248.
35. Tsushima H., Mori M. In vivo evidence that activation of tyrosine kinase is a trigger for lipopolysaccharide-induced fever in rats. Brain Res. 852:2000;367-373.
36. Watanabe T., Saiki Y., Sakata Y. The effect of central angiotensin II receptor blockade on interleukin-1β- and prostaglandin E-induced fevers in rats: possible involvement of brain angiotensin II receptor in fever induction. J. Pharmacol. Exp. Ther. 282:1997;873-881.
37. Yang W.W., Krukoff T.L. Nitric oxide regulates body temperature, neuronal activation and interleukin-1β gene expression in the hypothalamic paraventricular nucleus in response to immune stress. Neuropharmacology. 39:2000;2075-2089.
38. Zylber-Katz E., Granit L., Levy M. Formation and excretion of dipyrone metabolites in man. Eur. J. Clin. Pharmacol. 42:1992;187-191.